Oral Estradiol Cost in Wyoming 2026

What Does Oral Estradiol Actually Cost in Wyoming Right Now?

The average cash-pay price for a 30-day supply of generic oral estradiol at Wyoming retail pharmacies in 2026 is approximately $15 per month. The manufacturer list price sits closer to $40 per month, but virtually no cash-paying patient in Wyoming pays that figure because generic competition and discount cards drive the actual shelf price down sharply.

To put that in clinical context: oral estradiol tablets (estradiol 17-beta) are FDA-approved for moderate-to-severe vasomotor symptoms of menopause [1]. The Women's Health Initiative (WHI, JAMA 2002, N=16,608) remains the largest randomized trial of postmenopausal hormone therapy and showed that conjugated equine estrogen meaningfully reduced hot flashes, though it also raised questions about long-term cardiovascular and breast risk that clinicians still weigh individually [2]. Oral estradiol is a distinct formulation from conjugated estrogen, and its risk-benefit calculus is evaluated separately in current Menopause Society guidance [3].

Prices vary by pharmacy. Walgreens, Walmart, and Safeway locations in Cheyenne, Casper, and Laramie quoted 2026 cash prices between $10 and $22 per month for 1 mg tablets (30-count), depending on whether a discount card was applied. The $15 figure represents the statewide average across those chains. Patients using GoodRx or the manufacturer's generic savings card have reported prices as low as $9.84 per month at certain Wyoming ZIP codes.

The FDA's current drug label for oral estradiol tablets specifies that the lowest effective dose for the shortest duration consistent with treatment goals should be used [1]. That principle matters for cost, too: a patient stabilized on 0.5 mg daily spends less than one on 2 mg daily, even at the same per-tablet price.

Does Wyoming Medicaid Cover Oral Medicaid for Vasomotor Symptoms?

Wyoming Medicaid does not currently cover oral estradiol for the indication of moderate-to-severe vasomotor symptoms of menopause. This is consistent with a pattern seen in several other state Medicaid formularies that classify menopausal symptom relief as a lifestyle or non-acute condition and exclude it from the preferred drug list [4].

That exclusion leaves Wyoming Medicaid beneficiaries in a difficult position. The North American Menopause Society (NAMS) 2022 Position Statement states directly that "hormone therapy remains the most effective treatment for vasomotor symptoms" and that appropriate candidates should have access to it [3]. Access gaps created by Medicaid non-coverage run counter to that clinical standard.

Patients on Wyoming Medicaid who need oral estradiol have three practical options. They can pay cash (roughly $15/month), pursue a patient assistance program through the manufacturer, or ask their prescriber to document a more complex diagnostic rationale, such as premature ovarian insufficiency (POI), which may have a separate coverage pathway. POI affects roughly 1 in 100 women before age 40, and estrogen replacement for that indication is often treated differently in formulary decisions because it addresses a deficiency state rather than symptom relief [5].

Prior authorization requests for vasomotor symptom treatment are almost always denied under current Wyoming Medicaid policy, so clinicians should set realistic expectations with patients before submitting one.

Is Compounded Oral Estradiol Legal in Wyoming?

Yes. Compounded oral estradiol is legal in Wyoming when prepared by a 503A-licensed compounding pharmacy operating under a valid patient-specific prescription [6]. Wyoming follows federal USP standards for compounding and does not impose additional state-level restrictions beyond what federal law requires.

A 503A pharmacy compounds medications for individual patients based on a prescriber's order. This is different from a 503B outsourcing facility, which produces large batches without patient-specific prescriptions. For oral estradiol, 503A compounding is the relevant pathway.

Cost at a 503A pharmacy can be dramatically lower than retail. Several Wyoming-adjacent compounding pharmacies that ship into Wyoming legally have quoted $0 to $30 per month depending on the patient's specific plan, the dose, and whether a membership program applies. Some telehealth platforms include compounded estradiol in subscription plans at no additional drug cost.

The FDA's guidance on compounding makes clear that 503A pharmacies may compound estradiol in forms not commercially available, including specific micronized preparations or dose strengths not offered by brand manufacturers [6]. However, the FDA also warns that compounded hormones should not be marketed as safer or more effective than FDA-approved products without supporting evidence [7]. Clinicians at HealthRX review compounded vs. FDA-approved options with each patient individually.

One practical note: the USP <795> standards governing non-sterile compounding were updated in 2023 and apply to oral estradiol capsules and troches prepared at Wyoming 503A pharmacies [8]. Pharmacies must now meet stricter beyond-use dating, testing, and documentation requirements. Patients should verify that their compounding pharmacy has completed USP <795> compliance before filling.

Can You Get Oral Estradiol via Telehealth in Wyoming?

Telehealth prescribing of oral estradiol is fully legal in Wyoming for patients with a valid prescriber-patient relationship [9]. Wyoming adopted telehealth-friendly prescribing rules that allow controlled and non-controlled medications, including HRT, to be prescribed after a synchronous audio-video visit. Oral estradiol is not a controlled substance, which removes the additional DEA registration requirements that complicate remote prescribing of some other medications.

The Wyoming Board of Medicine requires that telehealth encounters meet the same standard of care as in-person visits. That means a prescriber must take a medical history, review relevant symptoms, and document a clinical rationale before issuing a prescription. A questionnaire alone is not sufficient.

For a patient in a rural Wyoming county such as Sublette or Niobrara, telehealth may be the only realistic access point for HRT consultation. Wyoming has 23 counties; only a handful have endocrinologists or gynecologists who regularly manage menopausal hormone therapy. A 2021 JAMA analysis found that rural patients face significantly longer wait times for specialist care than urban counterparts, a disparity that telehealth can partially address [10].

HealthRX providers licensed in Wyoming can prescribe oral estradiol following a telehealth visit. Prescriptions are then sent electronically to a pharmacy of the patient's choice, including mail-order pharmacies that serve Wyoming ZIP codes.

Which Insurance Plans Cover Oral Estradiol in Wyoming?

Private insurance coverage for oral estradiol in Wyoming varies by plan, but most major commercial plans include at least one generic oral estradiol on their formulary, typically at Tier 1 or Tier 2. Tier 1 generics usually carry copays of $0 to $15 per month after the deductible, though high-deductible health plans (HDHPs) common among Wyoming's self-employed and agricultural workers may require full cash-pay pricing until the deductible is met.

The Affordable Care Act's preventive care mandate requires plans to cover USPSTF-recommended preventive services without cost-sharing [11]. Oral estradiol for vasomotor symptom relief is not currently on the USPSTF preventive list, so that zero-cost-sharing rule does not apply. Women who receive oral estradiol specifically for osteoporosis prevention in conjunction with another primary indication may have a different coverage conversation with their insurer, but this is a narrow and case-specific scenario.

Wyoming's largest commercial insurers in 2026 include Blue Cross Blue Shield of Wyoming, Cigna, Aetna, and UnitedHealthcare. Each maintains its own preferred drug list. Generic estradiol tablets (1 mg, 30-count) appear on all four formularies as of the most recent publicly available PDL data, though the specific tier placement differs. Patients should call the member services number on their insurance card and ask specifically about the NDC for the generic estradiol tablet they are being prescribed, because different manufacturers' generics occasionally land on different tiers.

Employer-sponsored plans through Wyoming's state employee benefits program include oral estradiol as a covered generic, typically at a $10 per-month copay for a 30-day supply or $25 for a 90-day mail-order supply.

What Is the Cheapest Way to Get Oral Estradiol in Wyoming?

The lowest-cost pathway depends on the patient's specific situation. Here is how the options rank for most Wyoming cash-pay patients.

GoodRx and similar discount cards bring the retail price to $10, $18 per month at chains like Walmart and Kroger-affiliated stores. These cards are free to download and accepted at most Wyoming pharmacies. They cannot be combined with insurance, so patients must choose one or the other at the point of sale.

The HealthRX Wyoming Cost Decision Framework for oral estradiol works as follows. First, check whether your commercial insurance covers generic estradiol at Tier 1 or Tier 2; if yes, use insurance and the copay is likely $10, $15. Second, if you have an HDHP and have not met your deductible, compare the insurance negotiated price to the GoodRx cash price, and use whichever is lower. Third, if you are uninsured or on Wyoming Medicaid (which does not cover this indication), the GoodRx cash price of approximately $10, $18 per month is your baseline. Fourth, if a compounding pharmacy through a telehealth platform includes the drug in a monthly membership fee, that total cost may be lower still, particularly if the membership also covers the prescriber visit.

Mark Cuban's Cost Plus Drugs sells generic estradiol 1 mg tablets (90-count) for approximately $11 plus a dispensing fee as of 2026, which works out to roughly $4, $5 per month for a 1 mg daily dose [12]. Shipping to Wyoming is available. This price point is the lowest widely accessible option for most uninsured Wyoming patients.

Patient assistance programs from brand-name estradiol manufacturers are available but require income qualification and may involve paperwork delays of 2 to 4 weeks. They are worth pursuing for patients who qualify but are not the fastest solution.

How Generic Savings Cards Work in Wyoming

Generic savings cards, often called copay cards or discount cards, function as third-party payer arrangements at the pharmacy counter. The card issuer negotiates a discounted rate with pharmacy benefit managers and passes part of that savings to the patient.

GoodRx is the most widely used platform. The patient presents the card (physical or digital) at checkout, and the pharmacy runs the prescription through GoodRx's network rather than through insurance. The patient pays the GoodRx rate, which for generic oral estradiol in Wyoming averages around $12, $15 per month at Walgreens and CVS and around $9, $11 at Walmart.

Savings cards do not count toward insurance deductibles in most states. The Consolidated Appropriations Act of 2021 left open a significant loophole allowing insurers to exclude manufacturer copay card payments from deductible accumulation [13]. Wyoming has not passed state legislation closing this loophole, so patients using a savings card instead of insurance are not building toward their deductible. For patients with low annual prescription costs overall, this is rarely a problem. For patients with multiple prescriptions, it may be worth using insurance even if the per-prescription cost is slightly higher.

Savings card prices are pharmacy-specific and can change weekly. Patients should check the GoodRx website or app with their specific Wyoming ZIP code before driving to the pharmacy, because the price at a Cheyenne Safeway may differ from a Casper Walmart by several dollars.

What Do Current Guidelines Say About Who Should Take Oral Estradiol?

NAMS, the Endocrine Society, and the American College of Obstetricians and Gynecologists (ACOG) all endorse hormone therapy, including oral estradiol, for appropriate candidates with moderate-to-severe vasomotor symptoms [3, 14, 15]. The key clinical variables are age, time since menopause onset, and cardiovascular or breast cancer risk factors.

The "timing hypothesis," supported by re-analysis of WHI data and the KEEPS trial (Kronos Early Estrogen Prevention Study, N=727), holds that estrogen therapy started within 10 years of menopause onset or before age 60 carries a more favorable cardiovascular risk profile than therapy started later [16]. The KEEPS trial found no significant difference in carotid intima-media thickness progression between oral conjugated equine estrogen and transdermal estradiol versus placebo at 4 years, though it was not powered to detect cardiovascular events [16].

The Endocrine Society's 2015 clinical practice guideline on menopausal hormone therapy states: "We recommend against routine use of systemic hormone therapy in women older than 60 years or more than 10 years past menopause, except in specific clinical circumstances" [14]. That guidance does not prohibit use; it specifies that the risk-benefit discussion becomes more complex with increasing age.

Oral estradiol specifically undergoes first-pass hepatic metabolism, which raises sex hormone-binding globulin, C-reactive protein, and triglycerides more than transdermal estradiol does [17]. For patients with elevated triglycerides or a history of venous thromboembolism, transdermal estradiol is generally preferred. Patients without those risk factors may choose oral for its lower cost and simpler administration.

Oral Estradiol Dosing and Administration in Wyoming Clinical Practice

FDA-approved oral estradiol tablets are available in 0.5 mg, 1 mg, and 2 mg strengths [1]. The standard starting dose for vasomotor symptom treatment is 1 mg daily. Dose adjustment typically happens at 4 to 8 week intervals based on symptom response and tolerability.

Estradiol should be taken at the same time each day. Food does not significantly affect absorption. Missing a single dose does not require doubling the next dose.

Serum estradiol levels can be monitored, though routine monitoring is not required by guidelines for otherwise healthy patients on standard doses [3]. A serum estradiol level drawn 2 to 4 weeks after starting therapy gives a snapshot of systemic absorption and helps identify non-responders or over-responders. A target serum estradiol of 40, 100 pg/mL is a reasonable clinical reference range for postmenopausal women on low-dose therapy, though individual symptom response is the primary guide [14].

In patients with an intact uterus, oral estradiol must be combined with a progestogen to prevent endometrial hyperplasia [15]. The most common regimen in Wyoming clinical practice is oral estradiol 1 mg plus medroxyprogesterone acetate 2.5 mg daily (available as a combination tablet) or micronized progesterone 100 mg nightly. Patients who have had a hysterectomy do not need the progestogen component.

The FDA label recommends periodic reassessment, at least annually, of the continued need for therapy [1]. For women who began estradiol at age 52 for severe hot flashes, a re-evaluation at age 60 should include a discussion of whether symptoms persist, what the current evidence on long-term risks says, and whether a dose reduction or discontinuation trial is appropriate.